Scientists Are Trying to Define What 'Reversing Aging' Really Means
In a recent commentary published in Cell Metabolism, Harvard researchers Jesse Poganik and Vadim Gladyshev present a framework for judging whether anti‑aging treatments genuinely reverse biological age. The authors argue that a true reversal requires both a measurable shift in internal biomarkers and lasting improvement in physical and cognitive function.
Key Takeaways
- Biological age tests track patterns that change with age, and a lower score indicates a younger pattern.
- Researchers distinguish between slowing the aging process and actually becoming younger.
- Clinical trials, such as CALERIE, show mixed results across different aging biomarkers.
- Functional measures (muscle strength, cognition) and molecular markers should both be assessed.
- Three practical checks—consistency, persistence, orthogonal confirmation—are needed to validate claims.
| Metric | Value | Why it matters |
|---|---|---|
| Key Researchers | Jesse Poganik, Vadim Gladyshev | Lead scientists shaping the aging reversal debate. |
| Publication | Cell Metabolism commentary | Peer‑reviewed source of the framework. |
| CALERIE Trial Length | Two years | Duration of the calorie‑restriction study. |
| Primary Biomarker | DunedinPACE | Showed a small slowing of aging pace. |
What Is Biological Age?
Biological age estimates are derived from measurable features—such as DNA methylation patterns—that shift as people grow older. A lower score indicates that the measured features align more closely with those typical of younger individuals.
The Challenge of Defining Reversal
“Aging as a process is unidirectional and cannot be fully reversed, like time,” said Poganik. He explained that slowing the rate of aging is not the same as becoming younger, using the analogy of traveling more slowly along a road.
Measuring Change Inside the Body
Researchers propose combining internal biomarker shifts with assessments of functional capacity. They also emphasize the need to confirm that improvements persist after the intervention ends.
Functional Outcomes vs. Molecular Markers
In the CALERIE study, a 2023 analysis found a small slowing in aging pace using DunedinPACE, but PhenoAge and GrimAge showed no significant change. This highlights that different biomarkers can yield divergent results.
Some participants exhibit older biological ages yet maintain strong grip strength, hearing, and mobility. Those who prioritize function question whether such individuals should be labeled biologically older, while molecular proponents argue that early detection offers a window for intervention.
Practical Checks for Reversal Claims
Poganik outlines three essential tests: the same measurement must be used before and after treatment; the change must persist after the intervention stops; and the result should be reproduced using an orthogonal method. These checks help rule out regression to the mean and other statistical artifacts.
Future Directions and Competitions
The commentary cites XPRIZE Healthspan, which evaluates rejuvenation through muscle, cognitive, and immune function. Poganik notes that ongoing initiatives will provide critical data to refine the definition of true aging reversal.
Why It Matters
As anti‑aging therapies move into human trials, a clear, evidence‑based definition of reversal is essential for regulators, clinicians, and patients. Without it, claims of “younger” results risk being misleading or incomplete.
Frequently Asked Questions
Who are the main researchers behind this framework?
Harvard Medical School scientists Jesse Poganik and Vadim Gladyshev authored the Cell Metabolism commentary that outlines the proposed criteria.
What biomarkers were examined in the CALERIE trial?
The 2023 analysis evaluated DunedinPACE, PhenoAge, and GrimAge. Only DunedinPACE indicated a small slowing of the aging pace.
How does the commentary suggest verifying a reversal claim?
It recommends three checks: consistent measurement before and after, persistence of the change after treatment, and confirmation with an independent method.
What is XPRIZE Healthspan and why is it relevant?
It is a competition that assesses rejuvenation through muscle strength, cognition, and immune function, providing a real‑world benchmark for functional improvements.
Can a lower biological age score guarantee better health?
No. The commentary stresses that functional outcomes must also improve, and that molecular markers alone may not reflect changes in physical abilities.
Bottom Line
Defining true aging reversal requires evidence that a treatment lowers biological age scores, improves functional performance, and sustains those gains. Until such comprehensive criteria are met, claims of “younger” results should be interpreted with caution.
Reporting based on: original source.
Comments
Post a Comment